Overview

Bupivacaine vs Oxybuprocaine Topical Anesthesia in IVI

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
comparing two local anaesthetic agents, Bupivacaine 0.5% versus Oxybuprocaine used topically to provide surface anaesthesia before IVI procedures.
Phase:
Early Phase 1
Details
Lead Sponsor:
Research Institute of Ophthalmology, Egypt
Treatments:
Bupivacaine